- Home
- BKSY vs TNGX Comparison
BKSY vs TNGX Comparison
Compare BKSY & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKSY | TNGX |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 839.0M | 4.1B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BKSY | TNGX |
|---|---|---|
| Price | $21.67 | $21.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $28.50 | $21.78 |
| AVG Volume (30 Days) | 813.8K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.72 | ★ 26.89 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $62,384,000.00 |
| Revenue This Year | $27.03 | N/A |
| Revenue Next Year | $29.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $12.41 | $6.69 |
| 52 Week High | $52.88 | $34.39 |
Technical Indicators
Market Signals| Indicator | BKSY | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 42.40 | 37.46 |
| Support Level | $20.06 | $21.20 |
| Resistance Level | $24.35 | $25.64 |
| Average True Range (ATR) | 1.35 | 1.27 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 40.63 | 11.45 |
Price Performance
Historical ComparisonAbout BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.